Study of Difluprednate Ophthalmic Emulsion in the Treatment of Postoperative Inflammation

NCT00407225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation

Interventions

DRUG: Difluprednate Ophthalmic Emulsion

Sponsor

Sirion Therapeutics, Inc.